However, researchers saw that patients were experiencing a reduction in hunger and losing weight, enabling them to be licensed to treat obesity
Hemoglobin A1c levels tend to rise within weeks to months after discontinuation, returning toward pre-treatment values
If you experience any allergic reactions after using the product, discontinue if redness/irritation occurs
If you have consistent morning routines and can reliably maintain the fasting and waiting period requirements, oral administration integrates easily into daily patterns
What has been documented from these sources includes: Headaches, typically described as dull and short-lived Dizziness or light-headedness, particularly after injection Nausea or mild digestive discomfort, more common with oral forms Injection-site reactions including redness, swelling and irritation Appetite changes, sometimes reported as increased hunger Disrupted sleep when dosed in the evening Less commonly, palpitations or mood changes None of these has been formally linked to BPC-157 in peer-reviewed human studies